About Us
ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders.
More »
News
August 09, 2010
ACADIA Pharmaceuticals Reports Second Quarter 2010 Financial Results
August 02, 2010
ACADIA Pharmaceuticals to Announce Second Quarter 2010 Financial
Results on August 9, 2010
Product Candidates
We are developing a portfolio of four product candidates. Our most advanced product candidate is pimavanserin, which is being developed in collaboration with Biovail for three separate neurological and psychiatric indications, including a Phase III program for Parkinson's disease psychosis. In addition, we have a product candidate in
Phase II for chronic pain, a product candidate in Phase I for glaucoma, and a program in IND-track development for schizophrenia. More »
Company Information
 |
Request Information » |
 |
Investor Webcasts » |
 |
Email Updates » |